TwoStep Therapeutics raises $62.5 million in Series A led by Insight Partners, Medical Excellence Capital

• TwoStep Therapeutics raised a USD 62.5 million oversubscribed Series A led by Insight Partners, with Medical Excellence Capital as co-lead.
• M Ventures, Pfizer Ventures, NFX, 2048 Ventures participated; total capital raised reached USD 71.2 million.
• San Carlos-based biotech develops multi-specific targeted therapies for solid tumors using an integrin-binding peptide delivery platform.
• Proceeds support Phase 1 development of lead peptide-drug conjugate TS-104, following FDA IND clearance for first-in-human testing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medical Excellence Capital Partners LP published the original content used to generate this news brief on September 09, 2026, and is solely responsible for the information contained therein.